Hang Liu

机构：Huaihua University, Hunan University of Traditional Chinese Medicine, Sun Yat-sen University, Guilin Medical University, Anhui Medical University, The First Affiliated Hospital, Sun Yat-sen University, Hua Medicine (China) · ORCID：0000-0001-6862-0677

发表论文 27 篇 · 总被引 486 次 · h-index 12

代表论文

• Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer (2015 · Tumor Biology · 被引 78)
• MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma (2015 · Oncotarget · 被引 65)
• Integrated Analysis of miRNA and mRNA Expression Profiles Reveals Functional miRNA-Targets in Development Testes of Small Tail Han Sheep (2018 · G3 Genes Genomes Genetics · 被引 31)
• Claulansine F promoted the neuronal differentiation of neural stem and progenitor cells through Akt/GSK-3β/β-catenin pathway (2016 · European Journal of Pharmacology · 被引 25)
• Inhibition of miR-144-3p exacerbates non-small cell lung cancer progression by targeting CEP55 (2021 · Acta Biochimica et Biophysica Sinica · 被引 22)
• Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma (2024 · Journal of Translational Medicine · 被引 20)